JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 11, 2004; DOI: 10.1124/jpet.104.072504


0022-3565/05/3121-272-280$20.00
JPET 312:272-280, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.072504v1
312/1/272    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seyedi, N.
Right arrow Articles by Levi, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seyedi, N.
Right arrow Articles by Levi, R.

CARDIOVASCULAR

Histamine H3-Receptor-Induced Attenuation of Norepinephrine Exocytosis: A Decreased Protein Kinase A Activity Mediates a Reduction in Intracellular Calcium

Nahid Seyedi, Christina J. Mackins, Takuji Machida, Alicia C. Reid, Randi B. Silver, and Roberto Levi

Departments of Pharmacology (N.S., C.J.M., T.M., R.L.) and Physiology-Biophysics (A.C.R., R.B.S.), Weill Medical College of Cornell University, New York, New York

We had reported that activation of presynaptic histamine H3-receptors inhibits norepinephrine exocytosis from depolarized cardiac sympathetic nerve endings, an action associated with a marked decrease in intraneuronal Ca2+ that we ascribed to a decreased Ca2+ influx. An H3-receptor-mediated inhibition of cAMP-dependent phosphorylation of Ca2+ channels could cause a sequential attenuation of Ca2+ influx, intraneuronal Ca2+ and norepinephrine exocytosis. We tested this hypothesis in sympathetic nerve endings (cardiac synaptosomes) expressing native H3-receptors and in human neuroblastoma SH-SY5Y cells transfected with H3-receptors. Norepinephrine exocytosis was elicited by K+ or by stimulation of adenylyl cyclase with forskolin. H3-receptor activation markedly attenuated the K+- and forskolin-induced norepinephrine exocytosis; pretreatment with pertussis toxin prevented this effect. Similar to forskolin, 8-bromo-cAMP elicited norepinephrine exocytosis but, unlike forskolin, it was unaffected by H3-receptor activation, demonstrating that inhibition of adenylyl cyclase is a pivotal step in the H3-receptor transductional cascade. Indeed, we found that H3-receptor activation attenuated norepinephrine exocytosis concomitantly with a decrease in intracellular cAMP and PKA activity in SH-SY5Y-H3 cells. Moreover, pharmacological PKA inhibition acted synergistically with H3-receptor activation to reduce K+-induced peak intracellular Ca2+ in SH-SY5Y-H3 cells and norepinephrine exocytosis in cardiac synaptosomes. Furthermore, H3-receptor activation synergized with N- and L-type Ca2+ channel blockers to reduce norepinephrine exocytosis in cardiac synaptosomes. Our findings suggest that the H3-receptor-mediated inhibition of norepinephrine exocytosis from cardiac sympathetic nerves results sequentially from H3-receptor-Gi/Go coupling, inhibition of adenylyl cyclase activity, and decreased cAMP formation, leading to diminished PKA activity, and thus, decreased Ca2+ influx through voltage-operated Ca2+ channels.


Received June 8, 2004; accepted August 11, 2004.

Address correspondence to: Dr. Roberto Levi, Department of Pharmacology, Room LC419, 1300 York Ave., Weill Medical College of Cornell University, New York, NY 10021. E-mail: rlevi{at}med.cornell.edu




This article has been cited by other articles:


Home page
Mol. Interv.Home page
R. M. Fryer, G. A. Reinhart, and T. A. Esbenshade
Histamine in cardiac sympathetic Ganglia: a novel neurotransmitter?
Mol. Interv., February 1, 2006; 6(1): 14 - 19.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.